Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of T-2 toxin in the preparation of drugs for treating bone cancers and myeloproliferative disorder

A technology for myelodysplasia and toxins, used in drug combinations, anti-tumor drugs, bone diseases, etc., can solve problems that have not been found in research, and achieve good killing and inhibiting tumor cell growth.

Active Publication Date: 2009-08-26
SHENZHEN ICARBONX INTELLIGENT PEPTIDE PHARM TECH CO LTD
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010]The current research on T-2 toxin is mainly focused on its toxicity and pathogenicity to animals, and the use of T-2 toxin in bone cancer and bone marrow hyperplasia The study of drugs for the treatment of abnormal syndrome has not been found to be reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of T-2 toxin in the preparation of drugs for treating bone cancers and myeloproliferative disorder
  • Application of T-2 toxin in the preparation of drugs for treating bone cancers and myeloproliferative disorder

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] The present invention will be further described below with reference to specific examples, which are only used to illustrate the present invention, but do not limit the scope of the present invention.

[0020] Test 1: In vitro inhibitory effect of T-2 toxin on multiple myeloma

[0021] 1.1 Animals

[0022] SCID mice, 6 weeks old, weighing about 20g, half male and half female

[0023] 1.2 Cell lines and antibodies

[0024] IL-6-dependent human multiple myeloma cell line XG7, stimulated gpl30mAb

[0025] 1.3 Leak detection in SCID mice

[0026] The blood was collected from the venous plexus of SCID mice after ELISA with a capillary tube, the serum was separated, and the IgG content in the mouse serum was detected by ELISA.

[0027] 1.4 Culture of tumor cells

[0028] Human multiple myeloma cell line XG7 was cultured in RMPI-1640 containing 3 μg / ml IL-6 and 10% FCS at 37°C,

[0029] 5%CO 2 in the cell incubator. One week before transplantation, 5 μg / ml of stimulate...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a new use of T-2 toxin, that is, application of T-2 toxin in the preparation of drugs for treating bone cancers and myeloproliferative disorder, wherein the curative dose thereof is 0.1-20 mg / Kg (weight), preferably 0.5-8 mg / Kg (weight), during drug administration, the method comprises oral administration, intravenous injection, hypodermic injection and intramuscular injection. The invention establishes animal or cell models of multiple myeloma, osteosarcoma and myelodysplastic syndrome, and inspects the inhibition of the T-2 toxin on the tumors or tumor cells by injection or cell co-culture. The experiment shows that the T-2 toxin is capable of inhibiting the growth of tumor cells and has good killing effect on the bone cancers and myeloproliferative disorder.

Description

technical field [0001] The invention relates to the application of T-2 toxin in the preparation of medicaments for treating bone cancer and myelodysplasia. Background technique [0002] The etiology of bone tumors is still unknown. In the past, it was believed that injuries, especially chronic minor injuries and chronic infections, can cause bone tumors. In recent years, through experimental research, for example, fujinaga used sarcoma virus to make a large number of mouse osteosarcoma models, finkel used different types of isotopes and viruses to make osteosarcoma animal models, and some people used radioactive substances such as radium and strontium to make osteosarcoma animals. Model. These pathogenic factors have been identified by many scholars. The age of onset of bone tumors is 15 to 24 years old for males and 5 to 14 years old for females, which may be related to the time and duration of bone growth and endocrine development in different genders. [0003] Patholog...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/35A61P35/00A61P19/00
Inventor 厉保秋
Owner SHENZHEN ICARBONX INTELLIGENT PEPTIDE PHARM TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com